World Equity Group, Inc. Summit Therapeutics Inc. Transaction History
World Equity Group, Inc.
- $277 Billion
- Q3 2024
A detailed history of World Equity Group, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, World Equity Group, Inc. holds 14,842 shares of SMMT stock, worth $278,732. This represents 0.12% of its overall portfolio holdings.
Number of Shares
14,842
Previous 12,779
16.14%
Holding current value
$278,732
Previous $99.7 Million
226.1%
% of portfolio
0.12%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
192Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$459 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$206 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$148 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$102 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$65.1 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.78B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...